TILT Holdings Inc 8-K, filed Aug 14, 2023
TILT Holdings Inc. (TLLTF)
About this 8-K
TILT Holdings Inc filed this 8-K on August 14, 2023.
Items reported
- Item 2.02: Financial results
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number) |
(Address of principal executive offices) | (Zip Code) |
( |
(Registrant’s telephone number, including area code) |
Not applicable |
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.424) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.02 Results of Operations and Financial Condition.
On August 14, 2023, TILT Holdings Inc. (the “Company”) announced via press release its results for the second fiscal quarter ended June 30, 2023. A copy of the Company’s press release is hereby furnished and incorporated herein by reference as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(d) | Exhibits |
Exhibit |
| Description |
| | |
| ||
104 | | Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | TILT Holdings Inc. | |
| | | |
Date: August 14, 2023 | | By: | /s/ Tim Conder |
| | Name: | Tim Conder |
| | Its: | Interim Chief Executive Officer |
TILT Holdings Reports Second Quarter 2023 Results
PHOENIX, August 14, 2023 -- TILT Holdings Inc. (“TILT" or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, is reporting its financial and operating results for the three and six months ended June 30, 2023. All financial information is reported in U.S. dollars and prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) unless otherwise indicated.
“I am encouraged by the progress we have made since I rejoined the Company in April. We have instilled a stronger focus on cash management in order to achieve profitability and cash flow generation,” said Interim Chief Executive Officer, Tim Conder. “During the quarter, we identified and executed various cost saving measures and efficiency improvements through vendor rationalization, improved inventory management and decreased waste, and operational rightsizing. These initiatives are expected to result in annualized cost savings of approximately $8 million beginning in the third quarter of 2023.
“In addition to increased financial discipline and rigor, we are also refining our brand strategy to better leverage the strengths within our Jupiter business. Instead of underutilizing this competitive advantage as has been the case historically, we plan to lean into Jupiter’s’ distinct capability set by helping leading inhalation brands expand into new markets through our plant-touching footprint.
“Looking ahead, we are intently focused on cash flow generation and prioritizing the strength of our balance sheet as we work to pay down debt and grow our cash reserves. We will continue to execute on our strategic refinement plan while optimizing our brand portfolio to better align with our core competencies in inhalation. As we progress through the year, we are excited to better unify Jupiter and our plant-touching businesses while building the foundation for profitable growth in 2024 and beyond.”
Q2 2023 Financial Summary
| ● | Revenue was $41.6 million in the three months ended June 30, 2023, compared to $47.1 million in the prior year period, with the decrease primarily attributable to Jupiter driven by lower sales volume as well as a number of orders occurring, but not fulfilled, at the end of the quarter, and lower average price in certain product lines. This was partially offset by growth in the Company’s plant-touching business. |
| ● | Net loss was $26.9 million in the three months ended June 30, 2023, compared to a net loss of $7.1 million in the prior year period, with the difference primarily driven by $15.7 million of non-cash write down expenses related to inventory, investment and loans receivable in the second quarter of 2023. |
| ● | Adjusted EBITDA (non-GAAP) increased to $1.5 million in the three months ended June 30, 2023 compared to $1.1 million in the prior year period. The increase was primarily driven by early progress with the Company’s strategic refinement and optimization initiatives. |
| ● | At June 30, 2023, the Company had $4.1 million of cash, cash equivalents and restricted cash compared to $3.5 million at December 31, 2022. Notes payable net of discount at June 30, 2023 was $57.0 million compared to $59.7 million at December 31, 2022. |
Recent Financing Update
| ● | Simultaneous with the issuance of the Bridge Notes, the Company entered into a Consent, Confirmation, Limited Waiver and Forbearance Agreement with the noteholders of the February 2023 debt refinancing to suspend interest payments on the approximately $38 million in aggregate principal amount of amended and restated secured notes and approximately $8.2 million in aggregate principal amount of secured notes issued in February 2023. |
Q2 2023 Operational Highlights
| ● | Appointed Tim Conder, Board member and former President and Chief Operating Officer of the Company, as Interim Chief Executive Officer and Mark Scatterday, founder of Jupiter and former Chief Executive Officer of the Company, as senior advisor focused on the Company’s inhalation business. |
| ● | Appointed Brad Hoch, former Chief Financial Officer and current Chief Accounting Officer, as Interim Chief Financial Officer. |
| ● | Appointed Arthur “Art” Smuck to the Company’s Board of Directors. |
Earnings Call and Webcast
TILT management will host a conference call today at 5:00 p.m. Eastern time to discuss its financial and operational results.
Date: Monday, August 14, 2023
Time: 5:00 p.m. Eastern Time
Toll-free dial-in number: (877) 423-9813
International dial-in number: (201) 689-8573
Conference ID: 13740185
Webcast: TILT Q2 2023 Earnings Call
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Elevate IR at (720) 330-2829.
The conference call will also be broadcast live and available for replay in the investor relations section of the Company’s website at www.tiltholdings.com.
About TILT
TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 39 states in the U.S., as well as Canada, Israel, South America and the European Union. TILT’s core businesses include Jupiter Research LLC, a wholly-owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing; and cannabis operations, Commonwealth Alternative Care, Inc. in Massachusetts, Standard Farms LLC in Pennsylvania, Standard Farms Ohio, LLC in Ohio, and its partnership with the Shinnecock Indian Nation in New York. TILT is headquartered in Phoenix, Arizona. For more information, visit www.tiltholdings.com.
Forward-Looking Information
This news release contains forward-looking information and statements (together, “forward-looking information”) under applicable Canadian and U.S. securities laws which are based on current expectations. Forward-looking information is provided for the purpose of presenting information about TILT management’s current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward-looking information may include, without limitation, the expectations with respect to growth and profitability, the expected performance of TILT’s cost saving measures and efficiency improvements, the expected annualized cost savings, the ability to reduce debt and increase TILT’s cash reserves, the expected performance of the collaboration between TILT and its brand partners, the expected number of brand partner product offerings, anticipated development, timing and release of future product offerings, the ability to optimize operations, the opinions or beliefs of management, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies, and outlook of TILT, and includes statements about, among other things, future developments and the future operations, strengths and strategy of TILT. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, "will", “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. These statements should not be read as guarantees of future performance or results. These statements are based upon certain material factors, assumptions and analyses that were applied in drawing a conclusion or making a forecast or projection, including TILT’s experience and perceptions of historical trends, the ability of TILT to maximize shareholder value, current conditions and expected future developments, as well as other factors that are believed to be reasonable in the circumstances.
Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. TILT assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.
By its nature, forward-looking information is subject to risks and uncertainties, and there are a variety of risk factors, many of which are beyond the control of TILT, and that may cause actual outcomes to differ materially
from those discussed in the forward-looking statements. Such risk factors include, but are not limited to, TILT’s ability to continue as a going concern, TILT’s ability to generate sufficient liquidity, TILT’s ability to execute on its cost saving measures and initiatives and those risks described under the heading “Item 1A. Risk Factors” in the Annual Report on Form 10-K for the year ended December 31, 2022 filed by TILT, “Item 1A. Risk Factors” in the Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 and “Item 1A. Risk Factors” in the Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 filed by TILT, and other subsequent reports filed by TILT with the United States Securities and Exchange Commission at www.sec.gov and on SEDAR at www.sedar.com.
Non-GAAP Financial and Performance Measures
In addition to providing financial measurements based on GAAP, the Company provides additional financial metrics that are not prepared in accordance with GAAP. Management uses non-GAAP financial measures, in addition to GAAP financial measures, to understand and compare operating results across accounting periods, for financial and operational decision making, for planning and forecasting purposes and to evaluate the Company’s financial performance. These non-GAAP financial measures are EBITDA and Adjusted EBITDA. Management believes that these non-GAAP financial measures reflect the Company’s ongoing business in a manner that allows for meaningful comparisons and analysis of trends in the business, as they facilitate comparing financial results across accounting periods and to those of peer companies. Management also believes that these non-GAAP financial measures enable investors to evaluate the Company’s operating results and future prospects in the same manner as management. These non-GAAP financial measures may also exclude expenses and gains that may be unusual in nature, infrequent or not reflective of the Company’s ongoing operating results.
As there are no standardized methods of calculating these non-GAAP measures, the Company’s methods may differ from those used by others, and accordingly, the use of these measures may not be directly comparable to similarly titled measures used by others.
Accordingly, these non-GAAP measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP.
EBITDA and Adjusted EBITDA are financial measures that are not defined under GAAP. The Company uses these non-GAAP financial measures, and believes they enhance an investor’s understanding of the Company’s financial and operating performance from period to period, because they exclude certain material non-cash items and certain other adjustments management believes are not reflective of the Company’s ongoing operations and performance. The Company calculates EBITDA as net income (loss), plus (minus) income taxes (recovery), plus (minus) finance expense (income), plus depreciation and amortization expense. Adjusted EBITDA is EBITDA excluding certain one-time, non-cash or non-operating expenses, as determined by management, including stock compensation expense, debt issuance costs and severance.
Please see “Reconciliation of Non-GAAP Measures” below for further information.
Company Contact:
Lynn Ricci, VP of Investor Relations & Corporate Communications
TILT Holdings Inc.
lricci@tiltholdings.com
Investor Relations Contact:
Sean Mansouri, CFA
Elevate IR
TILT@elevate-ir.com
720.330.2829
Media Contact:
Leland Radovanovic
Trailblaze
TILT@trailblaze.com
Table 1: Condensed Consolidated Statements of Operations (Unaudited)
(Amounts Expressed in Thousands of United States Dollars)
| | Three Months Ended | | Six Months Ended | |||||||||||
|
| June 30, |
| March 31, |
| June 30, |
| June 30, |
| June 30, | |||||
| | 2023 | | 2023 | | 2022 | | 2023 | | 2022 | |||||
Revenues, net | | $ | 41,599 | | $ | 42,264 | | $ | 47,055 | | $ | 83,863 | | $ | 89,407 |
Cost of goods sold | | | (37,559) | | | (33,468) | | | (36,110) | | | (71,027) | | | (69,109) |
Gross profit | | | 4,040 | | | 8,796 | | | 10,945 | | | 12,836 | | | 20,298 |
| | | | | | | | | | | | | | | |
Operating expenses: | | | | | | | | | | | | | | | |
Wages and benefits | | | 5,871 | | | 5,784 | | | 6,335 | | | 11,655 | | | 11,503 |
General and administrative | | | 4,529 | | | 5,620 | | | 5,585 | | | 10,149 | | | 10,364 |
Sales and marketing | | | 290 | | | 404 | | | 586 | | | 694 | | | 993 |
Share-based compensation | | | (2,358) | | | 293 | | | 786 | | | (2,065) | | | 2,012 |
Depreciation and amortization | | | 4,712 | | | 4,129 | | | 4,560 | | | 8,841 | | | 9,118 |
Impairment loss and loss on disposal of assets | | | 4,947 | | | 188 | | | 6,669 | | | 5,135 | | | 7,366 |
Total operating expenses | | | 17,991 | | | 16,418 | | | 24,521 | | | 34,409 | | | 41,356 |
Operating loss | | | (13,951) | | | (7,622) | | | (13,576) | | | (21,573) | | | (21,058) |
| | | | | | | | | | | | | | | |
Other (expense) income: | | | | | | | | | | | | | | | |
Interest income | | | (64) | | | 64 | | | 56 | | | — | | | 74 |
Other income | | | 3 | | | 97 | | | 4 | | | 100 | | | 7 |
Change in fair value of warrant liability | | | — | | | — | | | 3,913 | | | — | | | 1,750 |
Gain on sale of assets | | | — | | | 8,401 | | | — | | | 8,401 | | | 1 |
Gain on foreign currency exchange | | | (1) | | | — | | | — | | | (1) | | | — |
Unrealized loss on investment | | | (6,400) | | | — | | | (49) | | | (6,400) | | | (94) |
Loan receivable losses | | | (5,200) | | | (388) | | | (504) | | | (5,588) | | | (1,021) |
Interest expense | | | (5,466) | | | (4,092) | | | (3,796) | | | (9,558) | | | (6,577) |
Total other (expense) income | | | (17,128) | | | 4,082 | | | (376) | | | (13,046) | | | (5,860) |
Loss from operations before income tax and non-controlling interest | | | (31,079) | | | (3,540) | | | (13,952) | | | (34,619) | | | (26,918) |
| | | | | | | | | | | | | | | |
Income taxes | | | | | | | | | | | | | | | |
Income tax benefit (expense) | | | 2,742 | | | (1,326) | | | 6,898 | | | 1,416 | | | 8,230 |
Net loss before non-controlling interest | | | (28,337) | | | (4,866) | | | (7,054) | | | (33,203) | | | (18,688) |
Less: Net income (loss) attributable to non-controlling interest | | | 1,442 | | | (9) | | | 3 | | | 1,433 | | | 8 |
Net loss attributable to TILT Holdings Inc. | | $ | (26,895) | | $ | (4,875) | | $ | (7,051) | | $ | (31,770) | | $ | (18,680) |
Table 2: Reconciliation of Non-GAAP Measures
(Amounts Expressed in Thousands of United States Dollars)
| | Three Months Ended | | Six Months Ended | |||||||||||
|
| June 30, |
| March 31, |
| June 30, |
| June 30, |
| June 30, | |||||
Net (loss) income before non-controlling interest | | $ | (28,337) | | $ | (4,866) | | $ | (7,054) | | $ | (33,203) | | $ | (18,688) |
| | | | | | | | | | | | | | | |
Add (Deduct) Impact of: | | | | | | | | | | | | | | | |
Interest income | | | 64 | | | (64) | | | (56) | | | — | | | (74) |
Interest expense | | | 5,466 | | | 4,092 | | | 3,796 | | | 9,558 | | | 6,577 |
Income tax expense (benefit) | | | (2,742) | | | 1,326 | | | (6,898) | | | (1,416) | | | (8,230) |
Depreciation and amortization | | | 6,695 | | | 5,980 | | | 6,128 | | | 12,675 | | | 12,296 |
Total Adjustments | | | 9,483 | | | 11,334 | | | 2,970 | | | 20,817 | | | 10,569 |
| | | | | | | | | | | | | | | |
EBITDA (Non-GAAP) | | $ | (18,854) | | $ | 6,468 | | $ | (4,084) | | $ | (12,386) | | $ | (8,119) |
| | | | | | | | | | | | | | | |
Add (Deduct) Impact of: | | | | | | | | | | | | | | | |
Share-based Compensation | | | (2,358) | | | 293 | | | 786 | | | (2,065) | | | 2,012 |
Severance | | | 884 | | | 66 | | | 94 | | | 950 | | | 94 |
Gain on Sale of Assets | | | — | | | (8,401) | | | — | | | (8,401) | | | (1) |
Legal Settlement | | | 93 | | | 165 | | | (360) | | | 258 | | | (360) |
Unrealized Loss on Investment in Equity Security | | | 6,400 | | | — | | | 49 | | | 6,400 | | | 94 |
Change in Fair Value of Financial Instruments | | | — | | | — | | | (3,913) | | | — | | | (1,750) |
Loss on Loan Receivable | | | 5,200 | | | 388 | | | 504 | | | 5,588 | | | 1,021 |
Impairment loss and loss on disposal of assets | | | 4,947 | | | 188 | | | 6,669 | | | 5,135 | | | 7,366 |
Foreign Exchange (Gain) Loss | | | 1 | | | — | | | — | | | 1 | | | — |
One Time Bad Debt Expense | | | — | | | 384 | | | — | | | 384 | | | — |
One Time Adjustments | | | 5,226 | | | 370 | | | 1,312 | | | 5,596 | | | 2,241 |
Total Adjustments | | | 20,393 | | | (6,547) | | | 5,141 | | | 13,846 | | | 10,717 |
| | | | | | | | | | | | | | | |
Adjusted EBITDA (Non-GAAP) | | | 1,539 | | | (79) | | | 1,057 | | | 1,460 | | | 2,598 |
Table 3: Condensed Consolidated Statements of Cash Flows (Unaudited)
(Amounts Expressed in Thousands of United States Dollars)
|
| Six Months Ended | ||||
|
| June 30, |
| June 30, | ||
Net Cash Provided by Operating Activities |
| $ | 440 |
| $ | 3,763 |
Net Cash Provided by (Used in) Investing Activities |
|
| 11,882 |
|
| (14,802) |
Net Cash (Used in) Provided by Financing Activities |
|
| (11,704) |
| 38,770 | |
Effect of Foreign Exchange on Cash and Cash Equivalents |
|
| (5) |
| (2) | |
Net Change in Cash and Cash Equivalents |
|
| 613 |
|
| 27,729 |
|
|
|
|
|
|
|
Cash and Cash Equivalents and Restricted Cash, Beginning of Period |
|
| 3,500 |
|
| 6,952 |
|
|
|
|
|
|
|
Cash and Cash Equivalents and Restricted Cash, End of Period |
| $ | 4,113 |
| $ | 34,681 |
Table 4: Condensed Consolidated Balance Sheets (Select Items)
(Amounts Expressed in Thousands of United States Dollars)
|
| Periods Ended | ||||
|
| June 30, |
| December 31, | ||
|
| (unaudited) |
| (audited) | ||
Cash and Cash Equivalents |
| $ | 2,815 |
| $ | 2,202 |
Restricted Cash |
|
| 1,298 |
|
| 1,298 |
Trade Receivables and Others |
|
| 26,086 |
|
| 26,698 |
Inventories |
|
| 36,826 |
|
| 52,909 |
Total Current Assets |
|
| 68,723 |
|
| 85,927 |
Property, Plant & Equipment, Net |
|
| 54,319 |
|
| 67,937 |
Total Assets |
|
| 258,218 |
|
| 293,978 |
Total Current Liabilities |
|
| 63,126 |
|
| 125,497 |
Total Long-Term Liabilities |
|
| 103,742 |
|
| 46,964 |
Total Shareholders’ Equity |
|
| 91,350 |
|
| 121,517 |
Table 5: Reconciliation of Non-GAAP Measures for Gross Profit
(Amounts Expressed in Thousands of United States Dollars)
| | Three Months Ended | | Six Months Ended | | |||||||||||
| | June 30, | | March 31, | | June 30, | | June 30, | | June 30, | | |||||
| | 2023 | | 2023 | | 2022 | | 2023 | | 2022 | | |||||
Revenues, net |
| $ | 41,599 |
| $ | 42,264 |
| $ | 47,055 |
| $ | 83,863 |
| $ | 89,407 |
|
Cost of goods sold | | | (37,559) | | | (33,468) | | | (36,110) | | | (71,027) | | | (69,109) | |
Gross profit $ | | | 4,040 | | | 8,796 | | | 10,945 | | | 12,836 | | | 20,298 | |
Gross profit % | | 9.7 | % | | 20.8 | % | | 23.3 | % | | 15.3 | % | | 22.7 | % | |
| | | | | | | | | | | | | | | | |
Add (Deduct) Impact of: | | | | | | | | | | | | | | | | |
One-time inventory adjustments | | | 4,878 | | | — | | | — | | | 4,878 | | | — | |
Total Adjustments | | | 4,878 | | | — | | | — | | | 4,878 | | | — | |
| | | | | | | | | | | | | | | | |
Adjusted Gross Profit $ (Non-GAAP) | | | 8,918 | | | 8,796 | | | 10,945 | | | 17,714 | | | 20,298 | |
Adjusted Gross Profit % (Non-GAAP) | | | 21.4 | % | | 20.8 | % | | 23.3 | % | | 21.1 | % | | 22.7 | % |